Ecolab Inc.

ECL
Financial Analysis · Updated May 13, 2026 · Coverage 2026-Q2
Latest Q Revenue
$4.1B
Q1 2026 · +10% YoY
TTM ROIC
11.5%
FY2025 · NOPAT / Invested Capital (Equity + Debt − Cash) · WACC ~8.5% · Moat spread +3pp
Margin Profile
Gross 44.5%
Operating 17%
FCF 11.8%
FY2025
Net Debt
$8.6B
Cash $520M · Debt $9.1B · Q1 2026

Business Overview


ticker: ECL step: 01 generated: 2026-05-12 source: quick-research

Ecolab Inc. (ECL) — Business Overview

Business Description

Ecolab is the global leader in water, hygiene, and infection prevention solutions, serving over 3 million customer locations across 170+ countries. Founded in 1923 and headquartered in Saint Paul, MN, the company occupies a uniquely defensive niche in specialty chemicals: its products are mission-critical for food safety, healthcare sanitation, industrial water efficiency, and facility hygiene — making them non-discretionary for customers. Ecolab's 90–95% recurring revenue model is underpinned by multi-year contracts where customers receive proprietary dispensing equipment at low cost but commit to purchasing Ecolab's chemical consumables, creating a razor/razorblade dynamic with high switching costs.

Revenue Model

Ecolab earns primarily recurring revenue from the sale of cleaning and sanitizing chemical products, water treatment chemicals, and related services under long-term contracts. The company embeds ~27,000 field sales and service associates directly at customer sites, providing hands-on technical support that deepens relationships and creates operational dependency. A growing "digital" revenue layer (up 25% in 2025) uses Ecolab's 1.1 trillion annual data points — gathered from sensors and systems installed at customer facilities — to offer predictive water and hygiene management services at premium pricing.

Products & Services

  • Global Water (~49% of revenue) — water treatment chemicals, process cleaning for industrials, food/beverage, energy, data centers, microelectronics
  • Global Institutional & Specialty (~40%) — cleaning and sanitizing for foodservice, hospitality, healthcare, lodging, education
  • Global Pest Elimination (~7%) — integrated pest management services for food, retail, healthcare facilities
  • Global Life Sciences (~4%) — contamination control for pharmaceutical/biotech manufacturers
  • Ecolab Digital — AI-powered water and hygiene management platform; predictive analytics and optimization
  • Global High-Tech — water solutions for data centers, semiconductor fabs (fastest-growing segment, 30%+ growth; Ovivo Electronics acquisition 2025)

Customer Base & Go-to-Market

Ecolab serves a diverse industrial and institutional customer base: food and beverage manufacturers, hotels, hospitals, restaurants, utilities, power plants, data centers, semiconductor manufacturers, and pharmaceutical plants. No single customer represents a significant percentage of revenue. The direct field sales model (27,000 associates) creates intimate customer relationships at the operational level — buyers are plant engineers, facilities managers, and chefs, not procurement — making the relationship sticky and price-inelastic.

Competitive Position

Ecolab holds a dominant position in water/hygiene chemistry that is genuinely difficult to challenge. Its competitive moat is multi-layered: (1) chemistry and formulation expertise protected by 10,000+ patents; (2) installed base of proprietary dispensing hardware at customer sites; (3) a proprietary data layer from 1.1 trillion annual sensor data points enabling predictive analytics competitors cannot replicate; and (4) a 27,000-person field service network that acts as a switching-cost barrier. Key competitors include Nalco Water (Ecolab-owned), ChemTreat, and Diversey — none of which match Ecolab's integrated chemistry+service+data model.

Key Facts

  • Founded: 1923 (Merrit J. Osborn, Minneapolis, MN)
  • Headquarters: Saint Paul, MN
  • Employees: ~47,000
  • Exchange: NYSE
  • Sector / Industry: Materials / Specialty Chemicals
  • Market Cap: ~$84B

Financial Snapshot


ticker: ECL step: 04 generated: 2026-05-12 source: quick-research

Ecolab Inc. (ECL) — Financial Snapshot

Income Statement Summary

Metric FY2022 FY2023 FY2024 YoY
Revenue ~$14.19B $15.32B $15.74B +3%
Gross Margin ~42% ~43% ~44.4% +1.4pp
Operating Margin ~14% ~16% ~18.4% +2.4pp
Net Income ~$0.98B ~$1.37B $2.11B +54%
EPS (diluted) $3.81 $4.79 $7.37 +54%

Note: FY2024 EPS growth of 54% reflects both operating leverage and the FY2022–2023 period when raw material cost headwinds compressed margins. FY2025 revenue was $16.08B (+2.2%); FY2025 net margin was 12.9% with $1.9B FCF and 17.0% operating margin.

Cash Flow & Balance Sheet (FY2024/2025)

Metric Value
Operating Cash Flow ~$2.5B
Free Cash Flow ~$1.9B (FY2025)
Cash & Equivalents ~$0.7B
Total Debt ~$8.5B

Key Ratios (approximate)

  • P/E: ~38x (FY2024 trailing) | EV/EBITDA: ~28x | FCF Yield: ~2.3%
  • Revenue Growth (FY2024): +3% | FCF Margin: ~12%
  • Dividend Yield: ~1.0% (Dividend Aristocrat; 30+ consecutive years of increases)

Growth Profile

Ecolab's organic revenue growth consistently runs at 4–7% per year, driven by pricing power (~3–4% annual price increases), volume growth from market share gains, and mix shift toward higher-margin segments (data centers, life sciences, digital services). The 2022–2023 period saw margin compression from commodity and supply chain inflation that is now fully recovered; FY2024's 54% EPS growth reflects this normalization plus structural margin expansion from the "One Ecolab" efficiency initiative (annualized savings target raised to $325M). Management targets 100–150 bps of annual EBIT margin expansion from 2027–2030, targeting 20%+ EBIT margins.

Forward Estimates

  • FY2025E Adj. EPS: $7.42–$7.62 (+12–15% YoY; company guidance)
  • FY2026E Revenue: ~$16.6–17.0B (consensus, ~3–5% organic growth)
  • FY2026E EPS: ~$8.30–8.60 (continued mid-teens adj. EPS growth)
  • Long-term EBIT margin target: 20%+ (vs. ~18% in FY2024)

Deeper Financial Analysis

The fundamental tier adds 9 additional research dimensions for $ECL.

Revenue Breakdown
Segment revenue, geographic mix, product-line contribution margins, and cohort dynamics.
Financial Trends
Quarter-over-quarter momentum, leading indicators, and inflection point analysis.
Balance Sheet
Debt structure, liquidity runway, dilution risk, and working capital dynamics.
Capital Allocation
Buyback cadence, M&A appetite, dividend policy, and reinvestment priorities.
Returns on Capital (ROIC)
Multi-year ROIC vs. WACC, marginal returns on reinvestment, sales-to-invested-capital efficiency, and moat spread.
GET /api/v1/research/ECL/fundamental$1.00 · Bearer token required
Markdown: /stocks/ecl/financials/md · → thesis · → memo